305 related articles for article (PubMed ID: 24595566)
1. Essential factors influencing health-related-quality of life in psoriasis.
Rønneberg Mehren C; Clemmensen A; Boe-Hansen Dall A; Philipsen P; Gniadecki R
J Drugs Dermatol; 2014 Mar; 13(3):246-50. PubMed ID: 24595566
[TBL] [Abstract][Full Text] [Related]
2. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study.
Daudén E; Pujol RM; Sánchez-Carazo JL; Toribio J; Vanaclocha F; Puig L; Yébenes M; Sabater E; Casado MA; Caloto MT; Aragón B;
Actas Dermosifiliogr; 2013 Nov; 104(9):807-14. PubMed ID: 23827342
[TBL] [Abstract][Full Text] [Related]
3. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.
Rosen CF; Mussani F; Chandran V; Eder L; Thavaneswaran A; Gladman DD
Rheumatology (Oxford); 2012 Mar; 51(3):571-6. PubMed ID: 22157469
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.
Brodszky V; Péntek M; Bálint PV; Géher P; Hajdu O; Hodinka L; Horváth G; Koó E; Polgár A; Seszták M; Szántó S; Ujfalussy I; Gulácsi L
Scand J Rheumatol; 2010 Aug; 39(4):303-9. PubMed ID: 20166848
[TBL] [Abstract][Full Text] [Related]
5. Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
Feldman SR; Gottlieb AB; Bala M; Wu Y; Eisenberg D; Guzzo C; Li S; Dooley LT; Menter A
Br J Dermatol; 2008 Sep; 159(3):704-10. PubMed ID: 18627375
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in psoriatic arthritis patients in Spain.
Gratacós J; Daudén E; Gómez-Reino J; Moreno JC; Casado MÁ; Rodríguez-Valverde V
Reumatol Clin; 2014; 10(1):25-31. PubMed ID: 24099960
[TBL] [Abstract][Full Text] [Related]
7. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
Youn SW; Lee JH; Yu DY; Kim Y; Kim BS; Seo SJ; Choe YB; Yun SK; Park J; Kim NI; Choi CW; Youn JI; Lee SJ; Lee MG; Kim KJ; Park CJ; Ro YS; Song HJ; Shin BS; Ahn SK; Lee JY; Won YH; Jang MS; Kim KH; Kim MH; Kim TY; Choi JH
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
Reich K; Krüger K; Mössner R; Augustin M
Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
[TBL] [Abstract][Full Text] [Related]
9. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
[TBL] [Abstract][Full Text] [Related]
10. Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial.
Kavanaugh A; Menter A; Mendelsohn A; Shen YK; Lee S; Gottlieb AB
Curr Med Res Opin; 2010 Oct; 26(10):2385-92. PubMed ID: 20831455
[TBL] [Abstract][Full Text] [Related]
11. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
Haugeberg G; Michelsen B; Kavanaugh A
RMD Open; 2020 May; 6(1):. PubMed ID: 32409518
[TBL] [Abstract][Full Text] [Related]
12. Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
Kalb RE; Blauvelt A; Sofen HL; Chevrier M; Amato D; Calabro S; Wang J; Schenkel B; Gottlieb AB
J Drugs Dermatol; 2013 Aug; 12(8):874-80. PubMed ID: 23986160
[TBL] [Abstract][Full Text] [Related]
13. Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey.
Moradi M; Rencz F; Brodszky V; Moradi A; Balogh O; Gulácsi L
Arch Iran Med; 2015 Mar; 18(3):153-9. PubMed ID: 25773688
[TBL] [Abstract][Full Text] [Related]
14. Disease characteristics in patients with and without psoriatic arthritis treated with etanercept.
Papp K; Poulin Y; Vieira A; Shelton J; Poulin-Costello M
J Eur Acad Dermatol Venereol; 2014 May; 28(5):581-9. PubMed ID: 23465037
[TBL] [Abstract][Full Text] [Related]
15. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.
Blackmore MG; Gladman DD; Husted J; Long JA; Farewell VT
J Rheumatol; 1995 May; 22(5):886-93. PubMed ID: 8587077
[TBL] [Abstract][Full Text] [Related]
16. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?
Tezel N; Yilmaz Tasdelen O; Bodur H; Gul U; Kulcu Cakmak S; Oguz ID; Karabulut E
Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852
[TBL] [Abstract][Full Text] [Related]
17. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
[TBL] [Abstract][Full Text] [Related]
18. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
19. The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies.
Kavanaugh A; Gottlieb A; Morita A; Merola JF; Lin CY; Birt J; Shuler CL; Hufford MM; Thaçi D
Ann Rheum Dis; 2019 Sep; 78(9):1215-1219. PubMed ID: 31113794
[TBL] [Abstract][Full Text] [Related]
20. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.
Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
Br J Dermatol; 2012 Apr; 166(4):797-802. PubMed ID: 22182212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
